Letter to Shareholders from Kraig Labs’ CEO, Kim Thompson
Today marks an important milestone for Kraig Labs and, with it, the opportunity to share an update across all aspects of our operations. This letter
Today marks an important milestone for Kraig Labs and, with it, the opportunity to share an update across all aspects of our operations. This letter
Ann Arbor, MI., November 21, 2022 – Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“Company” or “Kraig Labs”), the biotechnology company focused on the development and
Ann Arbor, MI., – September 12, 2022 – Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“Company” or “Kraig Labs”), the biotechnology company focused on the development
Ann Arbor, Michigan., – August 17, 2022– Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“Company” or “Kraig Labs”), the biotechnology company focused on the development and
Ann Arbor, Michigan., – August 4, 2022– Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“Company” or “Kraig Labs”), the biotechnology company focused on the development and
Ann Arbor, Michigan., – August 1, 2022– Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“Company” or “Kraig Labs”), the biotechnology company focused on the development and